Literature DB >> 33629107

COVID-19 pandemic impact on people with rheumatic and musculoskeletal diseases: Insights from patient-generated health data on social media.

Katja Reuter1, Atul Deodhar2, Souzi Makri3, Michael Zimmer4, Francis Berenbaum5, Elena Nikiphorou6.   

Abstract

OBJECTIVES: During the COVID-19 pandemic, much communication occurred online, through social media. This study aimed to provide patient perspective data on how the COVID-19 pandemic impacted people with rheumatic and musculoskeletal diseases (RMDs), using Twitter-based patient-generated health data (PGHD).
METHODS: A convenience sample of Twitter messages in English posted by people with RMDs was extracted between March 1, and July 12, 2020 and examined using thematic analysis. Included were Twitter messages that mentioned keywords and hashtags related to both COVID-19 (or SARS-CoV-2) and select RMDs. The RMDs monitored included inflammatory-driven (joint) conditions (Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis, Lupus/Systemic Lupus Erythematosus, and Gout).
RESULTS: The analysis included 569 tweets by 375 Twitter users with RMDs across several countries. Eight themes emerged regarding the impact of the COVID-19 pandemic on people with RMDs: (1) lack of understanding of SARS-CoV-2/COVID-19; (2) critical changes in health behaviour; (3) challenges in healthcare practice and communication with healthcare professionals; (4) difficulties with access to medical care; (5) negative impact on physical and mental health, coping strategies; (6) issues around work participation, (7) negative effects of the media; (8) awareness-raising.
CONCLUSION: The findings show that Twitter serves as a real-time data source to understand the impact of the COVID-19 pandemic on people with RMDs. The platform provided "early signals" of potentially critical health behaviour changes. Future epidemics might benefit from the real-time use of Twitter-based PGHD to identify emerging health needs, facilitate communication, and inform clinical practice decisions.
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology.

Entities:  

Keywords:  COVID-19; Twitter; coronavirus; patient-generated health data; rheumatic and musculoskeletal diseases; social media

Year:  2021        PMID: 33629107     DOI: 10.1093/rheumatology/keab174

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  4 in total

1.  Using patient-reported health data from social media to identify diverse lupus patients and assess their symptom and medication expressions: A feasibility study.

Authors:  Swamy Venuturupalli; Amit Kumar; Alden Bunyan; Nikhil Davuluri; Natalie Fortune; Katja Reuter
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-02-14       Impact factor: 5.178

2.  Real-world evidence for subcutaneous infliximab (CT-P13 SC) treatment in patients with psoriatic arthritis during the coronavirus disease (COVID-19) pandemic: A case series.

Authors:  Xenofon Baraliakos; Styliani Tsiami; Sooraj Vijayan; Haewon Jung; Nick Barkham
Journal:  Clin Case Rep       Date:  2022-01-20

3.  Minimal Impact of the COVID-19 Pandemic on Disease Activity and Health-Related Quality of Life in Patients With Ankylosing Spondylitis Receiving Bimekizumab: Exploratory Analyses From a Phase 2b Open-Label Extension Study.

Authors:  Philip C Robinson; Pedro M Machado; Nigil Haroon; Lianne S Gensler; John D Reveille; Vanessa Taieb; Thomas Vaux; Carmen Fleurinck; Marga Oortgiesen; Natasha de Peyrecave; Atul Deodhar
Journal:  ACR Open Rheumatol       Date:  2022-07-14

4.  Real-world evidence for subcutaneous infliximab (CT-P13 SC) treatment in patients with ankylosing spondylitis during the coronavirus disease (COVID-19) pandemic: A case series.

Authors:  Sooraj Vijayan; Kyungmin Hwangbo; Nick Barkham
Journal:  Clin Case Rep       Date:  2022-01-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.